These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28838145)

  • 1. Valganciclovir for the Suppression of Epstein-Barr Virus Replication.
    Yager JE; Magaret AS; Kuntz SR; Selke S; Huang ML; Corey L; Casper C; Wald A
    J Infect Dis; 2017 Jul; 216(2):198-202. PubMed ID: 28838145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valganciclovir administration to kidney donors to reduce the burden of cytomegalovirus and Epstein-Barr virus transmission during transplantation.
    Verghese PS; Schmeling DO; Knight JA; Matas AJ; Balfour HH
    Transplantation; 2015 Jun; 99(6):1186-91. PubMed ID: 25489844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial.
    Casper C; Krantz EM; Corey L; Kuntz SR; Wang J; Selke S; Hamilton S; Huang ML; Wald A
    J Infect Dis; 2008 Jul; 198(1):23-30. PubMed ID: 18491970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valganciclovir suppressed Epstein Barr virus reactivation during immunosuppression with alemtuzumab.
    Gill H; Hwang YY; Chan TS; Pang AW; Leung AY; Tse E; Kwong YL
    J Clin Virol; 2014 Apr; 59(4):255-8. PubMed ID: 24507802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of valganciclovir in liver-transplanted children infected with Epstein-Barr virus.
    Hierro L; Díez-Dorado R; Díaz C; De la Vega A; Frauca E; Camarena C; Muñoz-Bartolo G; González de Zárate A; López Santamaría M; Jara P
    Liver Transpl; 2008 Aug; 14(8):1185-93. PubMed ID: 18668670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of ganciclovir versus ganciclovir plus immune globulin for prophylaxis against Epstein-Barr virus related posttransplant lymphoproliferative disorder.
    Humar A; Hébert D; Davies HD; Humar A; Stephens D; O'Doherty B; Allen U
    Transplantation; 2006 Mar; 81(6):856-61. PubMed ID: 16570008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of valganciclovir on Epstein-Barr Virus polymerase chain reaction in pediatric liver transplantation: preliminary report.
    Venturi C; Bueno J; Gavalda J; Tórtola T; Pou L; Medina A; Codina G; Charco R; Pahissa A
    Transplant Proc; 2009 Apr; 41(3):1038-40. PubMed ID: 19376420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to valganciclovir in chronic fatigue syndrome patients with human herpesvirus 6 and Epstein-Barr virus IgG antibody titers.
    Watt T; Oberfoell S; Balise R; Lunn MR; Kar AK; Merrihew L; Bhangoo MS; Montoya JG
    J Med Virol; 2012 Dec; 84(12):1967-74. PubMed ID: 23080504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual presentation of Epstein-Barr virus hepatitis treated successfully with valganciclovir.
    Cauldwell K; Williams R
    J Med Virol; 2014 Mar; 86(3):484-6. PubMed ID: 24115018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome.
    Montoya JG; Kogelnik AM; Bhangoo M; Lunn MR; Flamand L; Merrihew LE; Watt T; Kubo JT; Paik J; Desai M
    J Med Virol; 2013 Dec; 85(12):2101-9. PubMed ID: 23959519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A therapeutic trial of valganciclovir in patients with uveitis and positive Epstein-Barr virus early antigen D IgG titers.
    Boonsopon S; Maghsoudlou A; Kombo NE; Foster CS
    Eur J Ophthalmol; 2016; 26(1):30-5. PubMed ID: 26350994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term shedding of infectious epstein-barr virus after infectious mononucleosis.
    Fafi-Kremer S; Morand P; Brion JP; Pavese P; Baccard M; Germi R; Genoulaz O; Nicod S; Jolivet M; Ruigrok RW; Stahl JP; Seigneurin JM
    J Infect Dis; 2005 Mar; 191(6):985-9. PubMed ID: 15717276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acyclovir efficiently inhibits oropharyngeal excretion of Epstein-Barr virus in patients with acute infectious mononucleosis.
    Ernberg I; Andersson J
    J Gen Virol; 1986 Oct; 67 ( Pt 10)():2267-72. PubMed ID: 3020162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe EBV hepatitis treated with valganciclovir.
    Pisapia R; Mariano A; Rianda A; Testa A; Oliva A; Vincenzi L
    Infection; 2013 Feb; 41(1):251-4. PubMed ID: 22837057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of high-dose ganciclovir for the treatment of cytomegalovirus replication in solid organ transplant patients with ganciclovir resistance-inducing mutations.
    Gracia-Ahufinger I; Gutiérrez-Aroca J; Cordero E; Vidal E; Cantisán S; del Castillo D; Martín-Gandul C; Rivero A; Torre-Cisneros J
    Transplantation; 2013 Apr; 95(8):1015-20. PubMed ID: 23407543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis.
    Balfour HH; Holman CJ; Hokanson KM; Lelonek MM; Giesbrecht JE; White DR; Schmeling DO; Webb CH; Cavert W; Wang DH; Brundage RC
    J Infect Dis; 2005 Nov; 192(9):1505-12. PubMed ID: 16206064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue.
    Kogelnik AM; Loomis K; Hoegh-Petersen M; Rosso F; Hischier C; Montoya JG
    J Clin Virol; 2006 Dec; 37 Suppl 1():S33-8. PubMed ID: 17276366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr and cytomegalovirus DNA salivary shedding correlate with long-term plasma HIV RNA detection in HIV-infected men who have sex with men.
    Scaggiante R; Andreis S; Basso M; Franchin E; Franzetti M; Del Vecchio C; Torti C; Mengoli C; Cruciani M; Sarmati L; Palù G; Parisi SG
    J Med Virol; 2016 Jul; 88(7):1211-21. PubMed ID: 26636290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (Val-)Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation.
    Höcker B; Böhm S; Fickenscher H; Küsters U; Schnitzler P; Pohl M; John U; Kemper MJ; Fehrenbach H; Wigger M; Holder M; Schröder M; Feneberg R; Köpf-Shakib S; Tönshoff B
    Transpl Int; 2012 Jul; 25(7):723-31. PubMed ID: 22533698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus infections: prospects for treatment.
    Gershburg E; Pagano JS
    J Antimicrob Chemother; 2005 Aug; 56(2):277-81. PubMed ID: 16006448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.